Ana G. Antun
Experienced in Hemolytic Anemia

Dr. Ana G. Antun

Hematology
Emory Hemophilia Of Georgia
550 Peachtree Street Northeast, MedicalOfficeTower, 
Atlanta, GA 
Offers Telehealth
30 Years of Experience
Experienced in Hemolytic Anemia
Emory Hemophilia Of Georgia
550 Peachtree Street Northeast, MedicalOfficeTower, 
Atlanta, GA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Ana Antun is a Hematologist in Atlanta, Georgia. Dr. Antun has been practicing medicine for over 30 years and is rated as an Experienced provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Hemophilia A, Thrombocytopenia, Purpura, Blood Clots, and Thrombectomy.

Her clinical research consists of co-authoring 30 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
National University Of Cordoba-Argentina, 1995
Residency
Albert Einstein College of Medicine of Yeshiva University
Specialties
Hematology
Licenses
Internal Medicine in GA
Board Certifications
American Board Of Internal Medicine, 2010
Fellowships
Emory University School of Medicine
Hospital Affiliations
Emory University Hospital Midtown
Languages Spoken
English
Spanish
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Emory Hemophilia of Georgia
550 Peachtree Street Northeast, MedicalOfficeTower, Atlanta, GA 30308

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3, Prospective, Randomized, Controlled, Open-label, Multicenter, 2 Period Crossover Study With a Single Arm Continuation Evaluating the Safety And Efficacy of BAX 930 (rADAMTS13) in the Prophylactic And On-demand Treatment of Subjects With Severe Congenital Thrombotic Thrombocytopenic Purpura (cTTP, Upshaw-Schulman Syndrome [USS], Hereditary Thrombotic Thrombocytopenic Purpura [hTTP])
A Phase 3, Prospective, Randomized, Controlled, Open-label, Multicenter, 2 Period Crossover Study With a Single Arm Continuation Evaluating the Safety And Efficacy of BAX 930 (rADAMTS13) in the Prophylactic And On-demand Treatment of Subjects With Severe Congenital Thrombotic Thrombocytopenic Purpura (cTTP, Upshaw-Schulman Syndrome [USS], Hereditary Thrombotic Thrombocytopenic Purpura [hTTP])
Enrollment Status: Completed
Publish Date: March 19, 2025
Intervention Type: Biological
Study Drug: BAX930
Study Phase: Phase 3
A Phase II, Open-label, Prospective, Single-arm, Study to Assess Ability of Eltrombopag to Induce Sustained Remission in Subjects With ITP Who Are Refractory or Relapsed After First-line Steroids
A Phase II, Open-label, Prospective, Single-arm, Study to Assess Ability of Eltrombopag to Induce Sustained Remission in Subjects With ITP Who Are Refractory or Relapsed After First-line Steroids
Enrollment Status: Completed
Publish Date: January 07, 2025
Intervention Type: Drug
Study Phase: Phase 2
Randomized Trial of Epsilon Aminocaproic Acid Versus Platelet Transfusions for the Prevention of Bleeding in Thrombocytopenic Patients With Hematological Malignancies
Randomized Trial of Epsilon Aminocaproic Acid Versus Platelet Transfusions for the Prevention of Bleeding in Thrombocytopenic Patients With Hematological Malignancies
Enrollment Status: Terminated
Publish Date: July 19, 2022
Intervention Type: Other, Drug
Study Drug: Epsilon Aminocaproic Acid
Study Phase: Phase 2
Adjuvant Low Dose Rituximab for Acquired TTP With Severe ADAMTS13 Deficiency
Adjuvant Low Dose Rituximab for Acquired TTP With Severe ADAMTS13 Deficiency
Enrollment Status: Completed
Publish Date: August 17, 2021
Intervention Type: Biological
Study Phase: Phase 2
View 3 Less Clinical Trials

30 Total Publications

Fetal and maternal morbidity in pregnant patients with thrombotic thrombocytopenic purpura: A Nationwide analysis.
Fetal and maternal morbidity in pregnant patients with thrombotic thrombocytopenic purpura: A Nationwide analysis.
Journal: Transfusion
Published: May 12, 2025
Similar Doctors
Elite in Hemolytic Anemia
Dr. Lakshmanan Krishnamurti
Hematology | Oncology
Elite in Hemolytic Anemia
Dr. Lakshmanan Krishnamurti
Hematology | Oncology
1405 Clifton Rd Ne, 
Atlanta, GA 
 (0.1 miles away)
404-785-1112
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Lakshmanan Krishnamurti is a Hematologist and an Oncologist in Atlanta, Georgia. Dr. Krishnamurti is rated as an Elite provider by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Hemolytic Anemia, and Bone Marrow Transplant. Dr. Krishnamurti is currently accepting new patients.

Advanced in Hemolytic Anemia
Dr. Lynn Zemsky
Hematology | Oncology
Advanced in Hemolytic Anemia
Dr. Lynn Zemsky
Hematology | Oncology

Nsh Cancer Institute Professional Services G LLC

790 Church St Ne, Suite 335, 
Marietta, GA 
 (18.0 miles away)
770-590-8311
Languages Spoken:
English
See accepted insurances

Lynn Zemsky is a Hematologist and an Oncologist in Marietta, Georgia. Dr. Zemsky is rated as an Advanced provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Paget Disease of the Breast, Thrombocytopenia, Anemia, and Familial Pancreatic Cancer.

Advanced in Hemolytic Anemia
Dr. Ayman S. Al-Hakim
Hematology Oncology | Hematology | Oncology
Advanced in Hemolytic Anemia
Dr. Ayman S. Al-Hakim
Hematology Oncology | Hematology | Oncology

Nsh Cancer Institute Professional Services G LLC

747 S 8th St, Suite C, 
Griffin, GA 
 (38.9 miles away)
770-228-1767
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ayman Al-Hakim is a Hematologist Oncology specialist and a Hematologist in Griffin, Georgia. Dr. Al-Hakim is rated as an Advanced provider by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Thrombocytopenia, Iron Deficiency Anemia, Hemolytic Crisis, and Congenital Hemolytic Anemia. Dr. Al-Hakim is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Antun's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 46 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile